The European Union approves a new injection method for monkeypox vaccine

Brussels (ST): The European Medicines Agency has allowed the use of a new technology related on how to inject the monkeypox vaccine, which legalizes the use of the vaccine and allows the vaccination of more than five times the number of people using the same amount of vaccines, which are clearly in short supply.

The British BBC reported that the European Medicines Agency’s advice is in line with the so-called “partial dose approach” approved by the regulators responsible for vaccines and medicines in the United States where one bottle of the vaccine can be used to produce up to five separate doses and can be used to vaccinate five people instead. It can be used to vaccinate one person by injecting a smaller amount between the layers of the skin instead of injecting it completely under the skin.

The vaccine, called “Genius”, “Amphanex” or “Amphamion”, was designed, depending on the region, to be injected into a layer of subcutaneous fat.

K.Q.